There has been increased interest in the clinical laboratory to develop comprehensive LC-MS/MS assays for urine drug testing, with fifty or more drugs and metabolites from multiple drug classes in a single method. These panels can increase throughput and improve laboratory efficiency, but also create many challenges.
Chemists and technologists, laboratory supervisors and managers, medical directors and R&D scientists in laboratories who develop, validate, or perform assays for urine drug testing.
This webinar was recorded on Thursday 9th March 2017
Stephanie J. Marin, Senior Applications Chemist at Biotage.
Stephanie J. Marin received her Ph.D. in chemistry from Arizona State University. She has expertise in sample preparation, liquid chromatography, and mass spectrometry. She has over 10 years of experience developing and validating clinical assays from her tenure at the ARUP Institute for Clinical and Experimental Pathology. She is the author of over 30 peer reviewed publications and book chapters and over 80 abstracts presented at national meetings.
Biotage Releases Isolera™ Dalton 2000
New ISOLUTE® FILTER+ Plates Prevents UPLC Clogging
Extraction of Oxytocin and Vasopressin from Serum Using EVOLUTE® EXPRESS ABN Prior to LC-MS/MS Analysis
The Role of LogP in Sample Preparation Methods
Biotage Awarded for Most Recognized Evaporator